AHC.ASX: Austco FY26 Results Media Release

Austco FY26 Results Media Release

Stock	Austco Healthcare Ltd (AHC.ASX)
Release Time	27 Aug 2026, 5:43 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Austco FY26 Results: Record Revenues and Growth in EBITDA and NPAT

Key Points

Total FY26 revenue grew by 16% to $94.2 million
Software and SMA revenues increased by 19% to $11.4 million
Gross margin improved to 53.4% from 52.0%
EBITDA grew by 14% to $14.9 million
NPAT increased by 52% to $9.0 million

Full Summary

Austco Healthcare Limited announced its FY26 results, highlighting a 16% increase in total revenues to $94.2 million. Software and SMA revenues grew by 19% to $11.4 million, contributing to a gross margin improvement from 52.0% to 53.4%. EBITDA increased by 14% to $14.9 million, and Net Profit After Tax (NPAT) surged by 52% to $9.0 million. The company's Unfilled Contracted Revenue (UCR) stood at $51.2 million at 17 August 2026, up 13% from the previous year. Austco's strong performance was driven by organic growth and the integration of acquisitions, with the company well-positioned for continued growth in FY27.

Guidance

FY26 revenue: $94.2 million, EBITDA: $14.9 million, NPAT: $9.0 million

Outlook

Austco Healthcare enters FY27 with confidence, supported by a growing software and maintenance base, $51.2 million in Unfilled Contracted Revenue, and the full benefit of lower input costs.